The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
As expected, to keep the SP down to lower their monthly payments. The only reason it was unclear, was because the holdings on the website hadn't been updated since January, which it still hasn't.
Broker reconciliation I would think.
Likewise, this morning's trades - 08:07:48
You'll have noticed that almost all of them were at the same time.
"All Share Options are valid for 10 years from the date of issue."
Seems clear to me, as per the below. Share options can only be vested between 3 - 10 years and only after a significant deal has been agreed. Therefore, if a deal is done tomorrow, they'll have to wait until 3 years, but if they haven't done a deal in 3 years, they'll have to wait for a significant deal, but before 10 years.
The question will be, what is a significant deal? Either way, Phase 3 will have been confirmed, and hopefully we will be much higher than where we are now.
The higher this goes, the more Lanstead pay monthly in the sharing agreement.
"do you think Tim should have stepped up earlier ?"
Yes, the share price dropped from 1.6p-1.8p range to 0.85p in a month, and Tim should have allayed fears earlier without having to be asked by small investors here. A "we have no idea why the SP is dropping" RNS would have also sufficed earlier. Also note that the website hasn't been updated, with regards to shareholdings, since 2nd January 2024, which would also help (unless Lanstead are selling but not reporting).
"all this for a ‘mere £300k’"
perhaps we needed an urgent short term loan and TB just didn't have the readies right now?
"Seller clearing out by the looks of it"
That doesn't entirely make sense imo. It's too convenient that the day a seller wants to off load a large amount of shares, there is a large demand for shares. Why is that demand not there any other day? I would suggest that there is demand first and it's Lanstead that are selling to keep the SP down.
My question is why the demand now? News due?
Where does it say on the website the start date for the adaptive phase 2/3 is 23/24? All i can find is:
Their pipleine states:
"Lupuzor™, (forigerimod or P140) is preparing to move into an adaptive phase 2/3 International pivotal trial in H2 – 2023."
Thanks everyone. That's very helpful. Interesting to get a better insight. Thanks.
Interesting site, thanks for that.
I know nothing about charts, but should this break out, where would the next pull back be?
British Bulls:
"The market is finally giving hints of a bullish resurgence. Today a bullish pattern is detected. Based on this pattern, in response to emerging market bullishness the system established new confirmation and stop loss levels. The signal tells us to STAY IN CASH, but the chance of a bullish confirmation that will change the signal to BUY is very high. The Delayed Intraday Module is ON. We strongly suggest you to follow the price action on an intraday basis in order to profit most from the early phase of a bull run."
Upto $25m is what has been agreed to, and we know of no amendments to this, so must assume that is still the agreement, however, I would add that, Avion aren't likely to walk away once they have spent $25m if there is a "probable" chance of success. They and IMM will renegotiate. So far the FDA have given positive guidance.
Nobody said anything about Lanstead buying shares in the market, but they have agreed to buy 50,000,000 shares. Both dallo and oscar22 have explained the share agreement better than I.
"the sharing agreement is an agreement to sell shares they have received into the market"
No it isn't, it's an agreement to BUY 50,000,000 shares, by paying for them on a monthly basis for 24 months (i.e. £41,666.66). However, if the SP is over 2p they pay more than that. If the SP is below 2p, they pay less. They don't have to sell any shares, but it is in their interest to keep the SP lower than 2p by selling into any demand.
Lanstead are capital investors, they provide funding, they're not running the company because they now have 22% (or whatever it is).
Alora/Avion are involved as a JV so they're not exactly questioning TM afterwards, they are heavily involved in the decision making, and wouldn't have agreed in the first place if they didn't think they had a good chance of success.
What a stupid post.
Not sure if this is limited to HL, but I can't buy. Tried £1k and £2k, no joy.
Whilst it's in Lanstead's interest to drip feed shares to keep the SP down, it all depends on how good the news will be, as to how low they can keep it. Lots of news due over next 6 months or so.
"To illustrate the potential for positive newsflow, we are entering a very important period for ImmuPharma as we move forward with the Phase 2/3 adaptive clinical trial in lupus. In addition, there is the prospect of reaching other key milestones over the next period. This includes concluding the licensing of Lupuzor™ for the ex-US rights; progressing our further late-stage asset, CIDP, where we are now gaining interest from potential partners to expedite this program and also to progress our earlier stage assets including BioAMB and BioCin within our anti-infective portfolio.
Note £0.2m cash left "but not including subsequent receipt of R&D tax credits, nor the subsequent ongoing monthly receipts from the existing two Lanstead Sharing Agreements from 2021 and 2022.